1366P Association between the adverse events and serum concentrations of lorlatinib in patients with advanced ALK-positive lung cancer
Shimoda, Y., Yoshida, T., Makihara, R.A., Torasawa, M., Tateishi, A., Matsumoto, Y., Shinno, Y., Okuma, Y., Goto, Y., Horinouchi, H., Yamamoto, N., Ohe, Y.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1249P Pharmacokinetic and dose finding study of osimertinib in patients with impaired renal function and low body weight
Hase, T., Fujiwara, Y., Makihara, R.A., Hashimoto, N., Tsubata, Y., Okuno, T., Naito, T., Takahashi, T., Kobayashi, H., Shinno, Y., Ikeda, T., Goto, K., Hosomi, Y., Watanabe, K., Kitazono, S., Sakiyama, N., Makino, Y., Yamamoto, N.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Dried plasma spot assay for sunitinib and its active metabolite by high performance liquid chromatography tandem mass spectrometry
Makihara, R.A., Maeda, M., Itahashi, K., Noda, S., Sato, J., Murakami, S., Goto, Y., Kanda, S., Fujiwara, Y., Horinouchi, H., Tsukamoto, T., Hashimoto, H., Makino, Y., Yamamoto, N., Ohe, Y., Terakado, H.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
Relationships between lenvatinib plasma concentration and toxicity in Japanese cancer patients
Makihara, R.A., Narita, S.N., Yamamoto, N., Sato, J., Murakami, S., Goto, Y., Kanda, S., Fujiwara, Y., Horinouchi, H., Tsukamoto, T., Hashimoto, H., Makino, Y., Ohe, Y., Yamaguchi, M.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article